Proteostatic modulation in brain aging without associated Alzheimer’s disease-and age-related neuropathological changes-Reference-Cited by-同舟云学术

Proteostatic modulation in brain aging without associated Alzheimer’s disease-and age-related neuropathological changes

Published:2023-05-13 Issue:9 Volume:15 Page:3295-3330
ISSN:1945-4589
Container-title:Aging
language:en
Short-container-title:Aging

Author:

Andrés-Benito Pol¹²,Íñigo-Marco Ignacio³,Brullas Marta²⁴,Carmona Margarita²⁴,Rio José Antonio del²⁵⁶,Fernández-Irigoyen Joaquín³,Santamaría Enrique³,Povedano Mónica¹²,Ferrer Isidro²⁴⁷

Affiliation:

1. Neurologic Diseases and Neurogenetics Group - Bellvitge Institute for Biomedical Research (IDIBE LL), L’Hospitalet de Llobregat, Barcelona 08907, Spain

2. CIBERNED (Network Centre of Biomedical Research of Neurodegenerative Diseases), Institute of Health Carlos III, L’Hospitalet de Llobregat, Barcelona 08907, Spain

3. Clinical Neuroproteomics Unit, Proteomics Platform, Proteored-ISCIII, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad Pública de Navarra (UPNA), diSNA, Pamplona 31008, Spain

4. Neuropathology Group, Institute of Biomedical Research, IDIBELL, L’Hospitalet de Llobregat, Barcelona 08907, Spain

5. Molecular and Cellular Neurobiotechnology Group, Institute of Bioengineering of Catalonia (IBEC), Barcelona Institute for Science and Technology, Science Park Barcelona (PCB), Barcelona 08028, Spain

6. Department of Cell Biology, Physiology and Immunology, Faculty of Biology, University of Barcelona, Barcelona 08007, Spain

7. Department of Pathology and Experimental Therapeutics, University of Barcelona, L’Hospitalet de Llobregat, Barcelona 08907, Spain

Publisher

Impact Journals, LLC

Subject

Cell Biology,Aging

Reference104 articles.

1. Alzheimer’s disease is an inherent, natural part of human brain aging: an integrated perspective.;Ferrer;Free Neuropathology,2022

2. Hypothesis review: Alzheimer's overture guidelines.;Ferrer;Brain Pathol,2023

3. Proteomic analysis of the brain in Alzheimer's disease: molecular phenotype of a complex disease process.;Cooper;Proteomics,2001

4. Semiquantitative proteomic analysis of human hippocampal tissues from Alzheimer's disease and age-matched control brains.;Diamandis;Clin Proteomics,2013

5. Quantification of the brain proteome in Alzheimer's disease using multiplexed mass spectrometry.;Shevchenko;J Proteome Res,2014

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proteostasis disruption and senescence in Alzheimer’s disease pathways to neurodegeneration;Brain Research;2024-12

2. Amyloid-β Pathology Is the Common Nominator Proteinopathy of the Primate Brain Aging;Journal of Alzheimer's Disease;2024-08-20

3. Diastolic dysfunction in Alzheimer’s disease model mice is associated with Aβ-amyloid aggregate formation and mitochondrial dysfunction;Scientific Reports;2024-07-19

4. How do neurons age? A focused review on the aging of the microtubular cytoskeleton;Neural Regeneration Research;2023-12-15